Tetragon Financial Group Limited November 2022 Monthly Factsheet

December 30, 2022

Tetragon has released its Monthly Factsheet for November 2022.

  • Net Asset Value: $2,694m
  • Fully Diluted NAV Per Share: $28.30
  • Share Price (TFG NA): $9.66
  • Monthly NAV per share total return: -0.1%
  • Monthly Return on Equity: 0.4%
  • Most recent quarterly dividend: $0.11
  • Dividend yield: 4.6%

Please refer to important disclosures on page three of the Monthly Factsheet.

Please click below to access the Monthly Factsheet.

November 2022 Factsheet 

About Tetragon

Tetragon is a closed-ended investment company that invests in a broad range of assets, including public and private equities and credit (including distressed securities and structured credit), convertible bonds, real estate, venture capital, infrastructure, bank loans and TFG Asset Management, a diversified alternative asset management business. Where appropriate, through TFG Asset Management, Tetragon seeks to own all, or a portion, of asset management companies with which it invests in order to enhance the returns achieved on its capital. Tetragon’s investment objective is to generate distributable income and capital appreciation. It aims to provide stable returns to investors across various credit, equity, interest rate, inflation and real estate cycles. The company’s non-voting shares are traded on Euronext in Amsterdam, a regulated market of Euronext Amsterdam N.V., and on the Specialist Fund Segment of the main market of the London Stock Exchange. For more information please visit the company’s website at www.tetragoninv.com.

Leave a Reply

Your email address will not be published.

Don't Miss

Prescient Appoints Three New Members to its Board of Directors

Prescient Healthcare Group, a leading biopharma product and portfolio strategy

iWantGreatCare and Top Doctors Merge to Become the Leading Company for Patient Reviews in the Healthcare Sector

Key Takeaways: Top Doctors and iWantGreatCare have merged to become